Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan;20(1):57-70.
doi: 10.5853/jos.2017.02796. Epub 2018 Jan 31.

Treatments to Promote Neural Repair after Stroke

Affiliations
Review

Treatments to Promote Neural Repair after Stroke

Steven C Cramer. J Stroke. 2018 Jan.

Abstract

Stroke remains a major cause of human disability worldwide. In parallel with advances in acute stroke interventions, new therapies are under development that target restorative processes. Such therapies have a treatment time window measured in days, weeks, or longer and so have the advantage that they may be accessible by a majority of patients. Several categories of restorative therapy have been studied and are reviewed herein, including drugs, growth factors, monoclonal antibodies, activity-related therapies including telerehabilitation, and a host of devices such as those related to brain stimulation or robotics. Many patients with stroke do not receive acute stroke therapies or receive them and do not derive benefit, often surviving for years thereafter. Therapies based on neural repair hold the promise of providing additional treatment options to a majority of patients with stroke.

Keywords: Neuronal plasticity; Recovery of function; Stroke; Stroke rehabilitation; Telerehabilitation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The brain progresses through three epochs after stroke. Each has a distinct biology defined by multiple processes ongoing in parallel. For each epoch, the general time scale, key therapeutic strategies, and main treatment approaches studied in preclinical and human studies are summarized.

References

    1. Johnston SC, Hauser SL. Neurological disease on the global agenda. Ann Neurol. 2008;64:A11–A12. - PubMed
    1. Writing Group Members. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133:e38–e360. - PubMed
    1. WRITING GROUP MEMBERS. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, et al. Heart disease and stroke statistics: 2010 update: a report from the American Heart Association. Circulation. 2010;121:e46–e215. - PubMed
    1. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–1329. - PubMed
    1. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–1587. - PubMed